How Analyst Views Are Shaping the Evolving Story for AbbVie

AbbVie’s consensus analyst price target has inched up from $237.48 to $241.29, reflecting renewed optimism surrounding the ...

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than ...

Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Protein Prep is delivering the broadest coverage of the blood ...